Human PLA2G7, recombinant (C-6His)

Human PLA2G7, recombinant (C-6His)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
NOV-C624.10ug 10 µg - -

10 - 15 business days*

150.00€
NOV-C624.50ug 50 µg - -

10 - 15 business days*

440.00€
NOV-C624.500ug 500 µg - -

10 - 15 business days*

1,540.00€
NOV-C624.1mg 1 mg - -

10 - 15 business days*

2,200.00€
 
Recombinant Human Platelet-Activating Factor Acetylhydrolase is produced by our Mammalian... more
Product information "Human PLA2G7, recombinant (C-6His)"
Recombinant Human Platelet-Activating Factor Acetylhydrolase is produced by our Mammalian expression system and the target gene encoding Phe22-Asn441 is expressed with a 6His tag at the C-terminus. Protein function: Lipoprotein-associated calcium-independent phospholipase A2 involved in phospholipid catabolism during inflammatory and oxidative stress response (PubMed:7700381, PubMed:8624782, PubMed:2040620, PubMed:16371369, PubMed:17090529, PubMed:10066756). At the lipid- aqueous interface, hydrolyzes the ester bond of fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity) (PubMed:2040620, PubMed:10504265). Specifically targets phospholipids with a short-chain fatty acyl group at sn-2 position (PubMed:2040620). Can hydrolyze phospholipids with long fatty acyl chains, only if they carry oxidized functional groups (PubMed:2040620, PubMed:8624782). Hydrolyzes and inactivates platelet-activating factor (PAF, 1-O-alkyl- 2-acetyl-sn-glycero-3-phosphocholine), a potent proinflammatory signaling lipid that acts through PTAFR on various innate immune cells (PubMed:10504265, PubMed:10066756, PubMed:7592717, PubMed:11590221, PubMed:7700381, PubMed:18434304, PubMed:16371369, PubMed:8675689, PubMed:8624782). Hydrolyzes oxidatively truncated phospholipids carrying an aldehyde group at omega position, preventing their accumulation in low-density lipoprotein (LDL) particles and uncontrolled proinflammatory effects (PubMed:2040620, PubMed:7700381). As part of high-density lipoprotein (HDL) particles, can hydrolyze phospholipids having long-chain fatty acyl hydroperoxides at sn-2 position and protect against potential accumulation of these oxylipins in the vascular wall (PubMed:17090529). Catalyzes the release from membrane phospholipids of F2-isoprostanes, lipid biomarkers of cellular oxidative damage (PubMed:16371369). [The UniProt Consortium]
Keywords: PAFAH, PLA2G7, gVIIA-PLA2, LDL-PLA(2), PAF 2-acylhydrolase, PAF acetylhydrolase, Group-VIIA phospholipase A2, LDL-associated phospholipase A2, Platelet-activating factor acetylhydrolase, 2-acetyl-1-alkylglycerophosphocholine esterase, Recombinant Human PL
Supplier: Novoprotein
Supplier-Nr: C624

Properties

Conjugate: No
Host: Human cells
Species reactivity: human
MW: 48.8 kD
Format: Solution

Database Information

KEGG ID : K01062 | Matching products
UniProt ID : Q13093 | Matching products

Handling & Safety

Storage: -80°C (avoid repeat freezing and thawing cycles)
Shipping: -20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Human PLA2G7, recombinant (C-6His)"
Write a review
or to review a product.
Viewed